Endocrine Metabolic & Immune Disorders-Drug Targets

Scope & Guideline

Connecting Research to Real-World Impact

Introduction

Immerse yourself in the scholarly insights of Endocrine Metabolic & Immune Disorders-Drug Targets with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1871-5303
PublisherBENTHAM SCIENCE PUBL LTD
Support Open AccessNo
CountryUnited Arab Emirates
TypeJournal
Convergefrom 2006 to 2024
AbbreviationENDOCR METAB IMMUNE / Endocr. Metab. Immune Disord.-Drug Targets
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressEXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES

Aims and Scopes

The journal 'Endocrine Metabolic & Immune Disorders-Drug Targets' focuses on the intersection of endocrinology, metabolism, and immunology, emphasizing the development of drug targets and therapeutic approaches for various disorders.
  1. Endocrinology and Hormonal Disorders:
    Research on the diagnosis, treatment, and management of various endocrine disorders, including thyroid diseases, adrenal insufficiencies, and hormonal imbalances.
  2. Metabolic Disorders:
    Exploration of metabolic diseases such as diabetes mellitus, obesity, and metabolic syndrome, including studies on their pathophysiology, risk factors, and effective interventions.
  3. Immune System Interactions:
    Investigation of the interactions between the immune system and endocrine/metabolic disorders, focusing on autoimmune diseases and inflammation.
  4. Herbal and Nutraceutical Therapies:
    Studies on the efficacy and mechanisms of herbal medicines, phytochemicals, and dietary supplements in managing endocrine and metabolic diseases.
  5. Innovative Drug Targets and Therapies:
    Research on novel pharmacological approaches, including drug development, targeted therapies, and biomarker identification for endocrine and metabolic disorders.
  6. Clinical Case Reports and Reviews:
    Publication of case reports and systematic reviews that provide insights into clinical practices and emerging trends in the management of endocrine and metabolic disorders.
Recent publications reflect a dynamic shift in research themes, indicating emerging trends that align with current healthcare challenges and scientific advancements.
  1. Integration of AI and Bioinformatics in Research:
    An increasing number of studies employ advanced bioinformatics and AI techniques to analyze complex data sets, highlighting a trend towards data-driven insights in understanding endocrine and metabolic disorders.
  2. Phytochemical Research and Natural Products:
    There is a growing interest in the therapeutic potential of plant-based compounds and nutraceuticals, emphasizing their role in managing metabolic and endocrine diseases.
  3. Interdisciplinary Approaches to Disease Management:
    Research is increasingly focused on interdisciplinary strategies that incorporate insights from nutrition, psychology, and lifestyle interventions in the management of endocrine and metabolic disorders.
  4. Longitudinal and Real-World Evidence Studies:
    An emerging trend is the emphasis on longitudinal studies and real-world evidence to assess treatment outcomes and disease progression in diverse populations.
  5. Focus on Immune-Endocrine Interactions:
    Research is increasingly exploring the interplay between the immune system and endocrine functions, particularly in the context of autoimmune diseases and metabolic syndrome.

Declining or Waning

While the journal has seen a rise in certain areas, some themes are experiencing a decline in prominence, reflecting changes in research focus and clinical significance.
  1. Traditional Endocrine Treatments:
    Research on conventional hormone replacement therapies is less frequently published, as there is a shift towards innovative and personalized approaches.
  2. Single-Cause Disease Models:
    There is a declining emphasis on studies that focus solely on single-cause models for diseases, as current research trends favor multifactorial approaches that consider genetic, environmental, and lifestyle factors.
  3. Standardized Drug Trials:
    The frequency of reporting on generalized, standardized drug trials is decreasing in favor of more rigorous, personalized medicine approaches that consider individual patient variability.
  4. Basic Science Studies:
    Fewer publications are focusing on basic science without direct clinical applications, as the journal increasingly prioritizes translational research that bridges laboratory findings with clinical practice.

Similar Journals

JOURNAL OF MOLECULAR ENDOCRINOLOGY

Connecting Molecular Biology and Endocrine Dynamics
Publisher: BIOSCIENTIFICA LTDISSN: 0952-5041Frequency: 6 issues/year

JOURNAL OF MOLECULAR ENDOCRINOLOGY, published by BIOSCIENTIFICA LTD, is a prestigious academic journal that has made significant contributions to the fields of endocrinology and molecular biology since its inception in 1988. With an impressive impact factor that places it in the Q1 category for Endocrinology and Q2 for Molecular Biology, this journal is recognized for its rigorous peer-reviewed research that addresses key questions at the intersection of molecular mechanisms and hormonal regulation. The journal's accessibility within the Scopus rankings, notably positioned 45th out of 128 in Endocrinology, highlights its relevance and influence in shaping contemporary scientific discourse. Although the journal does not currently offer open access options, it remains an essential resource for researchers, professionals, and students eager to explore groundbreaking discoveries and advancements in the hormonal sciences. The JOURNAL OF MOLECULAR ENDOCRINOLOGY continues to pave the way for critical exploration and innovation, ensuring its place as a vital publication for the advancement of knowledge in molecular endocrinology.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM

Advancing the Future of Pediatric Health
Publisher: WALTER DE GRUYTER GMBHISSN: 0334-018XFrequency: 12 issues/year

The JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, published by Walter de Gruyter GmbH, is a reputable peer-reviewed journal dedicated to advancing the field of pediatric endocrinology and metabolism. Since its inception in 1985, this journal has become a vital resource for professionals and researchers, providing insights into the latest advancements, clinical practices, and foundational research in the care of children with endocrine disorders. With a noted Q3 ranking in Endocrinology, Diabetes and Metabolism, and a robust focus on Pediatrics, Perinatology, and Child Health, it addresses important topics such as hormonal imbalances and metabolic syndromes in young populations. Despite its non-open access status, it continues to play an essential role in bridging the knowledge gap within our understanding of children's health and disease, contributing significantly to the progress in this specialized field.

ENDOCRINE RESEARCH

Pioneering discoveries in endocrine health.
Publisher: TAYLOR & FRANCIS INCISSN: 0743-5800Frequency: 4 issues/year

ENDOCRINE RESEARCH is a prominent peer-reviewed journal published by TAYLOR & FRANCIS INC, focused on the dynamic field of endocrinology. With an ISSN of 0743-5800 and an E-ISSN of 1532-4206, this journal has been contributing to the scientific community since 1974, providing a platform for researchers to disseminate innovative findings related to hormonal research and its implications in diverse medical contexts. Operating from the United States, it falls within the Q3 quartile ranking in both Endocrinology and Medicine (Miscellaneous), reflecting its recognized impact within these disciplines. While ENDOCRINE RESEARCH currently does not offer open access options, it remains an invaluable resource for professionals, students, and researchers seeking to stay at the forefront of endocrine science and clinical application. The journal invites original research articles, reviews, and case studies, fostering a collaborative environment for discussing the complexities of endocrinological phenomena.

International Immunopharmacology

Empowering Discoveries in Immunology and Pharmacological Applications
Publisher: ELSEVIERISSN: 1567-5769Frequency: 12 issues/year

International Immunopharmacology, published by Elsevier, stands as a prominent journal within the disciplines of immunology and pharmacology. With an ISSN of 1567-5769 and an E-ISSN of 1878-1705, this esteemed journal is based in the Netherlands and features a robust commitment to disseminating high-quality research from its inception in 2001 through 2024. The journal has achieved impressive rankings, securing a Q1 category in Pharmacology and Q2 in both Immunology and Immunology and Allergy as of 2023. With its strategic focus on bridging the gap between immunology and pharmacological applications, International Immunopharmacology attracts a diverse readership, including researchers, healthcare professionals, and students interested in the latest advancements in therapeutic agents and immune system modulation. Furthermore, it offers an open access option, enhancing the accessibility and reach of its invaluable content. As a pivotal resource in the field, this journal not only facilitates the exchange of innovative ideas but also fosters a deeper understanding of the complexities of immunopharmacology in today’s research landscape.

Journal of the Endocrine Society

Advancing endocrinology, one discovery at a time.
Publisher: ENDOCRINE SOCISSN: Frequency: 12 issues/year

Journal of the Endocrine Society, published by the ENDOCRINE SOC, stands as a prominent platform for disseminating significant research and findings within the field of endocrinology, diabetes, and metabolism. Established as an Open Access journal since 2017, it aims to increase the visibility and accessibility of vital scholarly contributions, allowing researchers and professionals from various backgrounds to engage with the latest insights in this rapidly evolving discipline. With an impressive Q2 ranking in Endocrinology, Diabetes and Metabolism, the journal is recognized for its impact, ranking #100 out of 244 in Scopus, highlighting its role in advancing scientific knowledge and fostering innovation. The journal, based in the United States at 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036, continues to enrich the academic landscape by converging state-of-the-art research and clinical applications through its publication cycle from 2017 to 2024. Researchers, students, and healthcare professionals are encouraged to explore this essential resource to stay at the forefront of endocrinological advancements.

BMC Endocrine Disorders

Connecting researchers to enhance endocrine health outcomes.
Publisher: BMCISSN: Frequency: 1 issue/year

BMC Endocrine Disorders is a leading open-access journal dedicated to advancing the field of endocrinology, diabetes, and metabolism. Published by BMC since 2001, this journal provides a vibrant platform for researchers to disseminate their findings across a wide array of topics related to endocrine health and disorders. With an impressive Q2 category ranking in both Endocrinology, Diabetes and Metabolism, and Medicine (miscellaneous) for 2023, it has positioned itself among the top-tier journals in its field, reflecting its commitment to high-quality research and discussions. The journal's accessibility enhances its reach and impact, ensuring that important findings are available to all stakeholders in the medical community. Researchers, healthcare professionals, and students alike will find valuable insights and updates that are crucial for both academic and practical applications within this dynamic field. The journal is actively welcoming submissions through 2024, facilitating continuous growth in the scientific discourse surrounding endocrine disorders.

Turkish Journal of Endocrinology and Metabolism

Unlocking Insights into Endocrine Health and Metabolic Science
Publisher: AVESISSN: 1301-2193Frequency: 4 issues/year

The Turkish Journal of Endocrinology and Metabolism, published by AVES, is a prominent platform dedicated to advancing research in the fields of endocrinology, diabetes, and metabolism. As an Open Access journal since 2002, it provides unrestricted access to its content, fostering a global exchange of knowledge among researchers, clinicians, and students. Operating from Turkey, this journal plays a crucial role in disseminating innovative findings related to endocrine disorders and metabolic diseases. While its current Q4 quartile rankings in both Endocrinology and Internal Medicine underscore areas for growth, they also signify the journal’s commitment to enhancing its impact within these disciplines. The journal emphasizes the development of locally relevant research while encouraging international contributions, thus bridging gaps in global health discourse. Engage with cutting-edge research that shapes clinical practices and informs public health policies by submitting your work or exploring the journal’s vast archive from 2009 to 2023.

Acta Endocrinologica-Bucharest

Empowering discoveries in diabetes and metabolic science.
Publisher: EDITURA ACAD ROMANEISSN: 1841-0987Frequency: 4 issues/year

Acta Endocrinologica-Bucharest is a vital resource for those engaged in the study and practice of endocrinology, diabetes, and metabolic research. Published by EDITURA ACAD ROMANE, this journal emphasizes the dissemination of high-quality research and insights specific to the fields of endocrinology and autonomic systems. Although categorized in the lower quartiles of its subject areas according to the latest rankings—Q4 in Endocrine and Autonomic Systems and Q4 in Endocrinology—it serves as an important platform for emerging scientific ideas and collaborative studies within the endocrinology community. With an ISSN of 1841-0987 and an E-ISSN of 1843-066X, the journal provides a significant opportunity for authors to contribute to the growing body of knowledge in these fields from its base in Romania. Researchers and practitioners alike will find valuable contributions that reflect both contemporary challenges and advances in endocrinology, reinforcing the journal's commitment to enhancing scholarly communication.

Journal of the ASEAN Federation of Endocrine Societies

Advancing Endocrinology: Bridging Knowledge Across ASEAN
Publisher: ASEAN FEDERATION ENDOCRINE SOCISSN: 0857-1074Frequency: 2 issues/year

Welcome to the Journal of the ASEAN Federation of Endocrine Societies, a pioneering publication dedicated to advancing knowledge and research in the fields of Endocrinology, Diabetes, and Metabolism. Established by the ASEAN Federation Endocrine Society and open access since 2011, this journal enhances the dissemination of critical findings and encourages collaboration among professionals and researchers across Southeast Asia and beyond. With an ISSN of 0857-1074 and E-ISSN of 2308-118X, the journal is indexed within Quartile 4 in the 2023 rankings of its categories, reflecting its commitment to providing a platform for scholarly work despite its emerging status. Situated in the Philippines, the journal focuses on the latest trends, treatments, and innovative research approaches in endocrinology, making it an essential resource for academics, clinicians, and students alike. We invite you to explore our content and contribute to advancing the endocrine sciences.

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo

Connecting research and practice in diabetes care.
Publisher: SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDMISSN: 1646-3439Frequency: 2 issues/year

Revista Portuguesa de Endocrinologia Diabetes e Metabolismo is a pivotal journal dedicated to advancing the fields of endocrinology, diabetes, and metabolism. Published by the esteemed SOC PORTUGUESA ENDOCRINOLOGIA, DIABETES & METABOLISMO-SPEDM, this journal serves as a platform for the dissemination of high-quality research, clinical studies, and innovative practices within these related disciplines. With a commitment to providing insightful and impactful content, the journal aims to foster knowledge sharing among researchers, healthcare professionals, and students interested in the latest developments in endocrine disorders and metabolic diseases. Although currently not open access, the journal's comprehensive approach and rigorous peer-review process ensure that it remains a respected source of information for its readers in Portugal and beyond. With its address rooted in the heart of Lisbon, the Revista Portuguesa de Endocrinologia Diabetes e Metabolismo plays a vital role in enhancing the understanding and treatment of endocrine and metabolic conditions in the modern healthcare landscape.